Literature DB >> 27193116

The relationship between mindfulness, pain intensity, pain catastrophizing, depression, and quality of life among cancer survivors living with chronic neuropathic pain.

Patricia A Poulin1,2,3,4,5, Heather C Romanow6, Noriyeh Rahbari6, Rebecca Small6,7, Catherine E Smyth8,6,9, Taylor Hatchard6,10, Brahm K Solomon10, Xinni Song11, Cheryl A Harris6,12,10, John Kowal6,12,10, Howard J Nathan8,6,9, Keith G Wilson6,13.   

Abstract

PURPOSE: This study aims to examine if mindfulness is associated with pain catastrophizing, depression, disability, and health-related quality of life (HRQOL) in cancer survivors with chronic neuropathic pain (CNP).
METHOD: We conducted a cross-sectional survey with cancer survivors experiencing CNP. Participants (n = 76) were men (24 %) and women (76 %) with an average age of 56.5 years (SD = 9.4). Participants were at least 1 year post-treatment, with no evidence of cancer, and with symptoms of neuropathic pain for more than three months. Participants completed the Five Facets Mindfulness Questionnaire (FFMQ), along with measures of pain intensity, pain catastrophizing, pain interference, depression, and HRQOL.
RESULTS: Mindfulness was negatively correlated with pain intensity, pain catastrophizing, pain interference, and depression, and it was positively correlated with mental health-related HRQOL. Regression analyses demonstrated that mindfulness was a negative predictor of pain intensity and depression and a positive predictor of mental HRQOL after controlling for pain catastrophizing, age, and gender. The two mindfulness facets that were most consistently associated with better outcomes were non-judging and acting with awareness. Mindfulness significantly moderated the relationships between pain intensity and pain catastrophizing and between pain intensity and pain interference.
CONCLUSION: It appears that mindfulness mitigates the impact of pain experiences in cancer survivors experiencing CNP post-treatment. IMPLICATIONS FOR CANCER SURVIVORS: This study suggests that mindfulness is associated with better adjustment to CNP. This provides the foundation to explore whether mindfulness-based interventions improve quality of life among cancer survivors living with CNP.

Entities:  

Keywords:  Cancer; Chronic neuropathic pain; Depression; Disability; Mindfulness; Quality of life

Mesh:

Year:  2016        PMID: 27193116     DOI: 10.1007/s00520-016-3243-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  37 in total

Review 1.  Neuropathic pain following breast cancer surgery: proposed classification and research update.

Authors:  Beth F Jung; Gretchen M Ahrendt; Anne Louise Oaklander; Robert H Dworkin
Journal:  Pain       Date:  2003-07       Impact factor: 6.961

Review 2.  Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis.

Authors:  Martine M Veehof; Maarten-Jan Oskam; Karlein M G Schreurs; Ernst T Bohlmeijer
Journal:  Pain       Date:  2011-01-19       Impact factor: 6.961

3.  Concordance between the PHQ-9 and the HSCL-20 in depressed primary care patients.

Authors:  Pamela W Lee; Herbert C Schulberg; Patrick J Raue; Kurt Kroenke
Journal:  J Affect Disord       Date:  2006-10-16       Impact factor: 4.839

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions.

Authors:  Michael J L Sullivan; Mary E Lynch; A J Clark
Journal:  Pain       Date:  2005-02       Impact factor: 6.961

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  A prospective analysis of acceptance of pain and values-based action in patients with chronic pain.

Authors:  Lance M McCracken; Kevin E Vowles
Journal:  Health Psychol       Date:  2008-03       Impact factor: 4.267

8.  Validation of the Brief Pain Inventory for chronic nonmalignant pain.

Authors:  Gabriel Tan; Mark P Jensen; John I Thornby; Bilal F Shanti
Journal:  J Pain       Date:  2004-03       Impact factor: 5.820

9.  Development and validation of the Neuropathic Pain Symptom Inventory.

Authors:  Didier Bouhassira; Nadine Attal; Jacques Fermanian; Haiel Alchaar; Michèle Gautron; Etienne Masquelier; Sylvie Rostaing; Michel Lanteri-Minet; Elisabeth Collin; Jacques Grisart; François Boureau
Journal:  Pain       Date:  2004-04       Impact factor: 6.961

10.  Psychometric properties of the Dutch Five Facet Mindfulness Questionnaire (FFMQ) in patients with fibromyalgia.

Authors:  Martine M Veehof; Peter M Ten Klooster; Erik Taal; Gerben J Westerhof; Ernst T Bohlmeijer
Journal:  Clin Rheumatol       Date:  2011-02-25       Impact factor: 2.980

View more
  23 in total

Review 1.  Putting Integrative Oncology Into Practice: Concepts and Approaches.

Authors:  Shelly Latte-Naor; Jun J Mao
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

2.  Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and Caregivers.

Authors:  Kelly Chinh; Ekin Secinti; Shelley A Johns; Adam T Hirsh; Kathy D Miller; Bryan Schneider; Anna Maria Storniolo; Lida Mina; Erin V Newton; Victoria L Champion; Catherine E Mosher
Journal:  Oncol Nurs Forum       Date:  2020-11-01       Impact factor: 2.172

3.  Mindfulness is associated with sleep quality among patients with fibromyalgia.

Authors:  Michelle Park; Yuan Zhang; Lori Lyn Price; Raveendhara R Bannuru; Chenchen Wang
Journal:  Int J Rheum Dis       Date:  2019-11-27       Impact factor: 2.454

4.  Mediators and moderators of change in mindfulness-based stress reduction for painful diabetic peripheral neuropathy.

Authors:  Karolina A Rozworska; Patricia A Poulin; Amanda Carson; Giorgio A Tasca; Howard J Nathan
Journal:  J Behav Med       Date:  2019-07-15

5.  Effectiveness of mindfulness-based supportive psychotherapy on posttraumatic growth, resilience, and self-compassion in cancer patients : A pilot study.

Authors:  Fatemeh Faghani; Azadeh Choobforoushzadeh; Mohammad Reza Sharbafchi; Hanieh Poursheikhali
Journal:  Wien Klin Wochenschr       Date:  2022-07-18       Impact factor: 2.275

6.  Mindfulness is associated with psychological health and moderates the impact of fibromyalgia.

Authors:  Brandon Pleman; Michelle Park; Xingyi Han; Lori Lyn Price; Raveendhara R Bannuru; William F Harvey; Jeffrey B Driban; Chenchen Wang
Journal:  Clin Rheumatol       Date:  2019-01-14       Impact factor: 2.980

Review 7.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

Review 8.  The relationship between trait mindfulness and affective symptoms: A meta-analysis of the Five Facet Mindfulness Questionnaire (FFMQ).

Authors:  Joseph K Carpenter; Kristina Conroy; Angelina F Gomez; Laura C Curren; Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2019-11-11

9.  A Comparison Between the Relaxation/Meditation/Mindfulness Tracker t Inventory and the Freiburg Mindfulness Inventory for Predicting General Health, Anxiety, and Anger in Adult General Population.

Authors:  Alireza Malakoutikhah; Mohammad Ali Zakeri; Mahlagha Dehghan
Journal:  Front Psychol       Date:  2022-04-04

10.  The Incidence of Mental Disorders Increases over Time in Patients with Cancer Pain: Data from a Retrospective Cohort Study.

Authors:  Michael Brinkers; Giselher Pfau; Anne-Marie Toepffer; Frank Meyer; Moritz A Kretzschmar
Journal:  Pain Res Manag       Date:  2021-06-03       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.